연구동향 분석
박사

유산균 투여가 비만 및 대사관련 지표에 미치는 영향 : 무작위배정, 이중맹검, 인체적용시험 = Effect of Probiotics on Obesity and Metabolic Disease-related Markers: a Double-blind, Placebo-controlled, Randomized Clinical Study

한경선 2018년

논문상세정보
인용/피인용
' 유산균 투여가 비만 및 대사관련 지표에 미치는 영향 : 무작위배정, 이중맹검, 인체적용시험 = Effect of Probiotics on Obesity and Metabolic Disease-related Markers: a Double-blind, Placebo-controlled, Randomized Clinical Study' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 약리학과 치료학
  • metabolites
  • microbiota
  • obesity
  • probiotics
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
963 0

0.0%

' 유산균 투여가 비만 및 대사관련 지표에 미치는 영향 : 무작위배정, 이중맹검, 인체적용시험 = Effect of Probiotics on Obesity and Metabolic Disease-related Markers: a Double-blind, Placebo-controlled, Randomized Clinical Study' 의 참고문헌

  • Zhang J, Kobert K, Flouri T, Stamatakis A. “PEAR: a fast and accurate Illumina Paired-End reAd mergeR”. Bioinformatics. Vol. 30(5), 2013.
  • Zhang C, Yin A, Li H, Wang R, Wu G, Shen J, et al. “Dietary Modulation of Gut Microbiota Contributes to Alleviation of Both Genetic and Simple Obesity in Children”, EBio Medicine, Vol. 2(8), 2015.
  • Yu Z, Zhai G, Singmann P, He Y, Xu T, Prehn C, et al. “Human serum metabolic profiles are age dependent”, Aging cell, Vol. 11(6), 2012.
  • Yanai H, Katsuyama H, Hamasaki H, Abe S, Tada N, Sako A. “Effects of Dietary Fat Intake on HDL Metabolism”. Journal of clinical medicine research, Vol. 7(3), 2015.
  • Wu T, Zhang Z, Liu B, Hou D, Liang Y, Zhang J, et al. “Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study”, BMC genomics, Vol 14, 2013.
  • World Health Organization. “Waist circumference and waist-hip ratio: Report of a WHO expert consultation, Geneva, 8-11 December 2008”. 2011.
  • World Health Organization. “The Asia-Pacific perspective: redefining obesity and its treatment”, Sydney: Health Communications Australia; 2000.
  • Van Gaal LF, Mertens IL, De Block CE. “Mechanisms linking obesity with cardiovascular disease”, Nature. Vol. 444(7121), 2006.
  • Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. “An obesity-associated gut microbiome with increased capacity for energy harvest”, Nature, Vol. 444(7122), 2006.
  • Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett C, Knight R, Gordon JI. “The human microbiome project: exploring the microbial part of ourselves in a changing world“, Nature, Vol. 449(7164), 2007.
  • Turnbaugh PJ, Gordon JI. “The core gut microbiome, energy balance and obesity”, The Journal of physiology, Vol. 587(17), 2009.
  • Takemura N, Okubo T, Sonoyama K. “Lactobacillus plantarum strain No. 14 reduces adipocyte size in mice fed high-fat diet”, Experimental biology and medicine, Vol. 235(7), 2010.
  • Takahashi S, Anzawa D, Takami K, Ishizuka A, Mawatari T, Kamikado K, et al. “Effect of Bifidobacterium animalis ssp. lactis GCL2505 on visceral fat accumulation in healthy Japanese adults: a randomized controlled trial”, Bioscience of microbiota, food and health, Vol. 35(4), 2016.
  • Stiemsma LT, Arrieta MC, Dimitriu PA, Cheng J, Thorson L, Lefebvre DL, et al. “Shifts in Lachnospira and Clostridium sp. in the 3-month stool microbiome are associated with preschool age asthma”, Clinical science, Vol. 130(23), 2016.
  • Smith-Brown P, Morrison M, Krause L, Davies PS. “Dairy and plant based food intakes are associated with altered faecal microbiota in 2 to 3 year old Australian children”, Scientific reports, Vol. 6, 2016.
  • Shin JH, Nam MH, Lee H, Lee JS, Kim H, Chung MJ, et al. “Amelioration of obesity-related characteristics by a probiotic formulation in a high-fat diet-induced obese rat model”, European journal of nutrition, 2017.
  • Sanchez M, Darimont C, Drapeau V, Emady-Azar S, Lepage M, Rezzonico E, et al. “Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women”. The British journal of nutrition, Vol. 111(8), 2014.
  • Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, et al. “Gut microbiota functions: metabolism of nutrients and other food components”, European journal of nutrition, 2017.
  • Rouxinol-Dias AL, Pinto AR, Janeiro C, Rodrigues D, Moreira M, Dias J, et al. “Probiotics for the control of obesity–Its effect on weight change”, Porto Biomedical Journal, Vol. 1(1), 2016.
  • Riviere A, Selak M, Lantin D, Leroy F, De Vuyst L. “Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut”, Frontiers in microbiology, Vol. 7, 2016.
  • Rist MJ, Roth A, Frommherz L, Weinert CH, Kruger R, Merz B, et al. “Metabolite patterns predicting sex and age in participants of the Karlsruhe Metabolomics and Nutrition (KarMeN) study”, PloS one, Vol. 12(8), 2017.
  • Ramautar R, Berger R, van der Greef J, Hankemeier T. “Human metabolomics: strategies to understand biology”, Current opinion in chemical biology, Vol. 17(5), 2013.
  • Pessione E. “Lactic acid bacteria contribution to gut microbiota complexity: lights and shadows”, Frontiers in cellular and infection microbiology, Vol. 2, 2012.
  • Perry AC, Applegate EB, Jackson ML, Deprima S, Goldberg RB, Ross R, et al. “Racial differences in visceral adipose tissue but not anthropometric markers of health-related variables”, Journal of applied physiology, Vol. 89(2), 2000.
  • Parks DH, Tyson GW, Hugenholtz P, Beiko RG. “STAMP: statistical analysis of taxonomic and functional profiles”, Bioinformatics, Vol. 30(21), 2014.
  • Park S, Bae JH. “Probiotics for weight loss: a systematic review and meta-analysis”, Nutrition research, Vol. 35(7), 2015.
  • Mujagic Z, de Vos P, Boekschoten MV, Govers C, Pieters HH, de Wit NJ, et al. “The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial”, Scientific reports, Vol. 7, 2017.
  • Minami J, Kondo S, Yanagisawa N, Odamaki T, Xiao JZ, Abe F, et al. “Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial”, Journal of nutritional science, Vol. 4, 2015.
  • Menni C, Kastenmuller G, Petersen AK, Bell JT, Psatha M, Tsai PC, et al. “Metabolomic markers reveal novel pathways of ageing and early development in human populations”, International journal of epidemiology, Vol. 42(4), 2013.
  • Matsuzawa Y, Nakamura T, Shimomura I, Kotani K. “Visceral fat accumulation and cardiovascular disease”, Obesity research, Vol. 3 (5), 1995
  • Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. “Diversity, stability and resilience of the human gut microbiota”, Nature, Vol. 489(7415), 2012.
  • Ley RE, Turnbaugh PJ, Klein S, Gordon JI. “Microbial ecology: human gut microbes associated with obesity”, Nature, Vol. 444(7122), 2006.
  • Lee K, Paek K, Lee HY, Park JH, Lee Y. “Antiobesity effect of trans-10,cis-12-conjugated linoleic acid-producing Lactobacillus plantarum PL62 on diet-induced obese mice”, Journal of applied microbiology, Vol. 103(4), 2007.
  • Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, et al. “Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences”, Nature biotechnology, Vol. 31(9), 2013.
  • Kondo S, Xiao JZ, Satoh T, Odamaki T, Takahashi S, Sugahara H, et al. “Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity”, Bioscience, biotechnology, and biochemistry, Vol. 74(8), 2010.
  • Kim JY, Park JY, Kim OY, Ham BM, Kim HJ, Kwon DY, et al. “Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS)”, Journal of proteome research, Vol. 9(9), 2010.
  • Kim HY, Kim M, Park HM, Kim J, Kim EJ, Lee CH, et al. “Lysophospholipid profile in serum and liver by high-fat diet and tumor induction in obesity-resistant BALB/c mice”, Nutrition, Vol. 30(11-12), 2014.
  • Kim HJ, Kim JH, Noh S, Hur HJ, Sung MJ, Hwang JT, et al. “Metabolomic analysis of livers and serum from high-fat diet induced obese mice”, Journal of proteome research, Vol. 10(2), 2011.
  • Karlsson CL, Molin G, F k F, Hagsl tt M-LJ, Jakesevic M, H kansson , et al. “Effects on weight gain and gut microbiota in rats given bacterial supplements and a high-energy-dense diet from fetal life through to 6 months of age”, British journal of nutrition, Vol. 106(6), 2011.
  • Kaess BM, Pedley A, Massaro JM, Murabito J, Hoffmann U, Fox CS. “The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk”, Diabetologia, Vol. 55(10), 2012.
  • Kadooka Y, Sato M, Imaizumi K, Ogawa A, Ikuyama K, Akai Y, et al. “Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial”, European journal of clinical nutrition, Vol. 64(6), 2010.
  • Jung SP, Lee KM, Kang JH, Yun SI, Park HO, Moon Y, et al. “Effect of Lactobacillus gasseri BNR17 on Overweight and Obese Adults: A Randomized, Double-Blind Clinical Trial”, Korean journal of family medicine, Vol. 34(2), 2013.
  • Jourdan C, Petersen AK, Gieger C, Doring A, Illig T, Wang-Sattler R, et al. “Body fat free mass is associated with the serum metabolite profile in a population-based study”, PloS one, Vol. 7(6), 2012.
  • Janssen I, Katzmarzyk PT, Ross R. “Waist circumference and not body mass index explains obesity-related health risk”, The American journal of clinical nutrition, Vol. 79(3), 2004.
  • Janssen I, Katzmarzyk PT, Ross R. “Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines”, Archives of internal medicine, Vol. 162(18), 2002.
  • Hove H, Norgaard H, Mortensen PB. “Lactic acid bacteria and the human gastrointestinal tract”, European journal of clinical nutrition, Vol. 53(5), 1999.
  • Fusco V, Quero GM, Cho GS, Kabisch J, Meske D, Neve H, et al. “The genus Weissella: taxonomy, ecology and biotechnological potential”, Frontiers in microbiology, Vol. 6, 2015.
  • Fukuda T, Bouchi R. “Ratio of visceral-to-subcutaneous fat area predicts cardiovascular events in patients with type 2 diabetes”, Journal of diabetes investigation, 2017.
  • Friedewald WT, Levy RI, Fredrickson DS. “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge”, Clinical chemistry, Vol. 18(6), 1972.
  • Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, et al. “Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity”, PNAS, Vol.110(22), 2013.
  • Dror T, Dickstein Y, Dubourg G, Paul M. “Microbiota manipulation for weight change”, Microbial pathogenesis, Vol. 106, 2017.
  • Drissi F, Raoult D, Merhej V. “Metabolic role of lactobacilli in weight modification in humans and animals”, Microbial pathogenesis, Vol. 106, 2017.
  • Despres JP. “Cardiovascular disease under the influence of excess visceral fat”, Critical pathways in cardiology, Vol. 6(2), 2007.
  • De Wit N, Derrien M, Bosch-Vermeulen H, Oosterink E, Keshtkar S, Duval C, et al. “Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine”, American Journal of Physiology–Gastrointestinal and Liver Physiology, Vol. 303(5), 2012.
  • Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, et al. “Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology”, Gut, Vol. 65(3), 2016.
  • Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E, et al. “Dietary intervention impact on gut microbial gene richness”, Nature, Vol. 500(7464), 2013.
  • Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. “Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men”, Diabetes care, Vol. 17(9), 1994.
  • Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. “QIIME allows analysis of high-throughput community sequencing data”, Nature methods, Vol. 7(5), 2010.
  • Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al. “Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice”, Diabetes, Vol. 57(6), 2008.
  • Caesar R, Tremaroli V, Kovatcheva-Datchary P, Cani PD, Backhed F. “Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling”, Cell metabolism, Vol. 22(4), 2015.
  • Bolger AM, Lohse M, Usadel B. “Trimmomatic: a flexible trimmer for Illumina sequence data”, Bioinformatics, Vol. 30(15), 2014.
  • Barreto FM, Colado Sim o AN, Morimoto HK, Batisti Lozovoy MA, Dichi I, Helena da Silva Miglioranza L. “Beneficial effects of Lactobacillus plantarum on glycemia and homocysteine levels in postmenopausal women with metabolic syndrome”, Nutrition, Vol. 30(7), 2014.
  • Balamurugan R, George G, Kabeerdoss J, Hepsiba J, Chandragunasekaran AM, Ramakrishna BS. “Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children”, The British journal of nutrition, Vol. 103(3), 2010.
  • Allam-Ndoul B, Guenard F, Garneau V, Cormier H, Barbier O, Perusse L, et al. “Association between Metabolite Profiles, Metabolic Syndrome and Obesity Status”, Nutrients, Vol. 8(6), 2016.